Literature DB >> 26517775

Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma.

Ken Takizawa1, Takatoshi Sorimachi1, Hideo Ishizaka1, Takahiro Osada1, Kittipong Srivatanakul1, Hiroaki Momose1, Mitsunori Matsumae1.   

Abstract

OBJECT The middle meningeal artery (MMA) is suspected to play an important role in the development of chronic subdural hematoma (CSDH). The aim of this study was to clarify whether the MMA was enlarged in patients with CSDHs. METHODS The authors retrospectively assessed 55 patients in whom CSDH was diagnosed between 2010 and 2014 and who underwent MR angiography (MRA) after the onset of CSDH. The authors compared MMA diameters between hemispheres with and without CSDHs on MR angiograms. A case-control study was also performed with 55 sex- and age-matched patients with incidental unruptured aneurysms as controls. RESULTS In 55 patients with CSDHs, the diameters of the 79 MMAs on the CSDH side were significantly larger than the diameters of the 31 MMAs on the non-CSDH side (p < 0.05). In 24 patients with bilateral CSDHs, no significant difference was found between the MMA diameters on the larger hematoma side and those on the smaller hematoma side. In 13 patients who underwent MRA before the onset of the CSDH, the MMAs on MR angiograms acquired after onset of the CSDH were significantly larger than those on MR angiograms acquired before the CSDH onset (p < 0.05). The diameters of the MMAs in 55 patients with CSDHs were significantly larger than those of the MMAs in the 55 control patients (p < 0.05). CONCLUSIONS The MMA is enlarged with development of a CSDH. Information about the MMA observed on MRA in patients with CSDHs may be useful in developing a strategy for future treatment of CSDHs.

Entities:  

Keywords:  CSDH = chronic subdural hematoma; MIP = maximum-intensity projection; MMA = middle meningeal artery; MRA = MR angiography; TOF = time of flight; chronic subdural hematoma; magnetic resonance angiography; middle meningeal artery; trauma

Mesh:

Year:  2015        PMID: 26517775     DOI: 10.3171/2015.5.JNS1567

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Recurrence and Coniglobus Volumetric Resolution of Subacute and Chronic Subdural Hematoma Post-Middle Meningeal Artery Embolization.

Authors:  Ambooj Tiwari; Adam A Dmytriw; Ryan Bo; Nathan Farkas; Phillip Ye; David S Gordon; Karthikeyan M Arcot; David Turkel-Parrella; Jeffrey Farkas
Journal:  Diagnostics (Basel)       Date:  2021-02-07

2.  The "Shiny and Thick High Heel Sign" : A novel radiologic sign for detecting intracranial dural arteriovenous fistulas with time-of-flight magnetic resonance angiography.

Authors:  Hannes Schacht; Inke Regina König; Johannes Hensler; Peter Schramm; Jan Küchler; Claudia Ditz; Alexander Neumann
Journal:  Clin Neuroradiol       Date:  2021-06-08       Impact factor: 3.156

Review 3.  Clinical importance of the middle meningeal artery: A review of the literature.

Authors:  Jinlu Yu; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-10-17       Impact factor: 3.738

Review 4.  Chronic Subdural Hematoma in Elderly Patients: Is This Disease Benign?

Authors:  Masaaki Uno; Hiroyuki Toi; Satoshi Hirai
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-06-26       Impact factor: 1.742

5.  Angiogenesis in the Septum and Inner Membrane of Refractory Chronic Subdural Hematomas: Consideration of Findings after Middle Meningeal Artery Embolization with Low-concentration n-butyl-2-cyanoacrylate.

Authors:  Hiroshi Saito; Michihiro Tanaka; Hiromu Hadeishi
Journal:  NMC Case Rep J       Date:  2019-09-14

6.  Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A National Database Study of 191 Patients in the United States.

Authors:  Anna M Nia; Visish M Srinivasan; Rishi R Lall; Peter Kan
Journal:  World Neurosurg       Date:  2021-06-29       Impact factor: 2.210

Review 7.  Middle Meningeal Artery Embolization for Chronic Subdural Hematoma.

Authors:  Joshua S Catapano; Candice L Nguyen; Andre A Wakim; Felipe C Albuquerque; Andrew F Ducruet
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.